Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a fast-growing cancer of the blood and bone marrow that results in the overproduction of immature white blood cells, leading to symptoms like fatigue, frequent infections, and easy bruising.
Blood Cancer Treatment: Allo-RevCAR01-T-CD123
We are testing a new therapy for patients with certain blood cancers that have CD123 markers. This study aims to evaluate the safety and dosage of this innovative treatment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Charite Universitaetsmedizin Berlin KöR
Department of Hematology, Oncology and Tumor Immunology
Berlin, Germany
Technische Universitat Dresden
Early Clinical Trial Unit
Dresden, Germany
Universitaetsklinikum Ulm AöR
Department of Internal Medicine lll
Klingenstein, Germany
Sponsor: AvenCell Europe GmbH
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.